Table 1 Patient characteristics
|  | n = 39 |
|---|---|
Age (y) | 73.8 ± 6.5 |
Sex (male/female) | 31/8 |
Body mass index (kg/m2) | 22.2 ± 3.4 |
CEA (ng/mL) | 3.9 ± 2.9 |
CA19-9 (U/mL) | 659.0 ± 2284.9 |
SUV-max of FDG-PET | 7.5 ± 5.2 |
Tumor size (mm) | 35.8 ± 16.4 |
Tumor type (Papillary/Nodular/Flat) | 2/25/12 |
T Stage (1/2/3/4) | 2/18/14/5 |
Nodal status (N0/N1/N2) | 25/11/3 |
Lymphatic invasion (-/ +) | 18/21 |
Vascular invasion (-/ +) | 18/21 |
Nerve invasion (-/ +) | 9/30 |
UICC Stage (I/IIA/IIB/IIIA/IIIB/IV) | 2/13/16/3/5/0 |
pS6 score | 3.9 ± 1.4 |
GLUT1 score | 4.0 ± 1.5 |